Department profile
Bird & Bird

Pharma/Life Sciences: Product Liability

France Guide 2026 : France


Bird & Bird

Rankings

About

Provided by Bird & Bird

With more than 280 experts worldwide and a wealth of experience working with life sciences companies and regulatory bodies, our clients choose us as their strategic partner to help them tackle some of their most complex legal challenges.

In France, our team of 23 lawyers, including 8 partners & 1 counsel, is one of the largest in the sector and supports all players in the sector, including pharmas, start-ups (biotechs, medtechs, healthtech), university spin-out, financial institutions, hospitals, public organisations, equipment manufacturers, retailers, & Clinical research organisations.

Multidisciplinary assistance

Our expertise is based on the need to understand the scientific, ethical & commercial challenges faced by companies & organisations in the sector and to take account of these in a pragmatic and commercial way in the support we provide to our clients. Most of our lawyers are qualified scientists and/or have worked in industry & regulatory bodies before becoming lawyers. Their expertise & know-how mean that they are regularly involved in large-scale international projects & disputes.

We guide our clients through incorporation, development and financing, intellectual property exploitation and portfolio management, regulatory and contractual issues, clinical trials and obtaining marketing authorisation through a unique offering of skills in IP, corporate, regulatory, AI, data protection, licensing & commercial transactions, EU & competition, employment and tax law.

Chambers Review

Provided by Chambers

Pharma/Life Sciences: Product Liability - France


What the Team is Known For

Bird & Bird houses a renowned practice advising on a range of corporate mandates in the pharma and life sciences sector, including fundraisings and acquisitions. The team is also adept at advising on intellectual property and regulatory matters. The law firms handles French and cross-border cases, collaborating with its network of offices globally.

À propos de l’équipe

Bird & Bird est un cabinet renommé qui conseille sur une gamme de mandats corporate dans le secteur pharmaceutique et des sciences de la vie, y compris des levées de fonds et des acquisitions. L’équipe est également apte à fournir des conseils sur les questions de propriété intellectuelle et de réglementation. Le cabinet d’avocats traite des dossiers français et transfrontaliers, en collaboration avec son réseau de bureaux dans le monde entier.

Work Highlights

Provided by Chambers

  • Bird & Bird advised Coave Therapeutics on its Series A2 financing round led by Bpifrance and Novo Holding.

  • Bird & Bird a conseillé Coave Therapeutics lors de son tour de financement de série A2 mené par Bpifrance et Novo Holding.

Strengths

Provided by Chambers

  • They got us so quickly on risk strategy, they understood our mission and made my life so much easier.

    Pharma/Life Sciences: Product Liability respondentFrance
  • Ils ont très vite cerné notre stratégie de gestion des risques, ils ont compris notre objectif et m'ont grandement facilité la tâche.

    Pharma/Life Sciences: Product Liability respondentFrance

Notable Practitioners

Provided by Chambers

  • Band 2Emmanuelle Porte
    Band 2Emmanuelle Porte

    Emmanuelle Porte

    Emmanuelle Porte handles a range of corporate matters in the pharmaceutical sector, including acquisitions and fundraisings.

    Emmanuelle Porte traite de nombreux dossiers corporate dans le secteur pharmaceutique, notamment des acquisitions et des levées de fonds.

  • Up and ComingCharles-Henri Caron
    Up and ComingCharles-Henri Caron

    Charles-Henri Caron

    Charles-Henri Caron represents French and international pharmaceutical clients in product liability cases. He joined Bird & Bird in September 2025.

    Charles-Henri représente des clients pharmaceutiques français et internationaux dans des affaires de responsabilité du fait des produits. Il a rejoint Bird & Bird en Septembre 2025.

    • Charles-Henri is responsive, available and has solid expertise. He works in both French and English, coordinates cases and demonstrates very good commercial sense.

      Pharma/Life Sciences: Product Liability respondentFrance
    • Charles-Henri est réactif, disponible et possède une solide expertise. Il travaille aussi bien en français qu'en anglais, coordonne les dossiers et fait preuve d'un excellent sens des affaires.

      Pharma/Life Sciences: Product Liability respondentFrance

Ranked Individuals at Bird & Bird (2)

France

Members

Provided by Bird & Bird

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership